Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 17, Issue 1-2, 2016, Pages 101-111

  Proudfoot, Malcolm ^a   Menke, Ricarda A L ^a   Sharma, Rakesh ^a   Berna, Claire M ^a   Hicks, Stephen L ^a   Kennard, Christopher ^a   Talbot, Kevin ^a   Turner, Martin R ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

anti saccade; cognitive; eye tracking; magnetic resonance imaging; Motor neuron disease; saccade; trail making

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR CINGULATE; ARTICLE; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; EYE TRACKING; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PHYSICAL DISABILITY; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; SACCADIC SUPPRESSION; TASK PERFORMANCE; TRAIL MAKING TEST; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; OCULOGRAPHY; OCULOMOTOR NERVE DISEASES; PATHOPHYSIOLOGY; REPRODUCIBILITY; SACCADIC EYE MOVEMENT; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COGNITION; COGNITION DISORDERS; EYE MOVEMENT MEASUREMENTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCULOMOTOR NERVE DISEASES; REPRODUCIBILITY OF RESULTS; SACCADES; SENSITIVITY AND SPECIFICITY;

EID: 84955704141     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2015.1054292     Document Type: Article

References (87)

1. Turner MR, Swash M, Ebers GC. Lockhart Clarkes contribution to the description of amyotrophic lateral sclerosis. Brain: a journal of neurology. 2010; 133: 3470-9.
2. Sharma R, Hicks S, Berna CM, et al. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Archives of Neurology. 2011; 68: 857-61.
3. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. Journal of Neurology, Neurosurgery, and Psychiatry. 2012; 83: 102-8.
4. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011; 76: 1263-9.
5. Cipresso P, Meriggi P, Carelli L, et al. editors. The combined use of Brain Computer Interface and Eye-Tracking technology for cognitive assessment in Amyotrophic Lateral Sclerosis. International Workshop on Pervasive Computing Paradigms for Mental Health; 2012.
6. Shaunak S, Orrell RW, OSullivan E, et al. Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment. Annals of Neurology. 1995; 38: 38-44.
7. Hicks SL, Sharma R, Khan AN, et al. An eye-Tracking version of the trail-making test. PloS One. 2013; 8: e84061.
8. Machts J, Bittner V, Kasper E, et al. Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neuroscience. 2014; 15: 83.
9. Taylor LJ, Brown RG, Tsermentseli S, et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? Journal of Neurology, Neurosurgery, and Psychiatry. 2013; 84: 494-8.
10. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293-9.
11. Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology. 2006; 66: 647-53.
12. Mioshi E, Dawson K, Mitchell J, et al. The Addenbrookes Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006; 21: 1078-85.
13. Bowie CR, Harvey PD. Administration and interpretation of the Trail Making Test. Nat Protoc. 2006; 1: 2277-81.
14. Menke RA, Korner S, Filippini N, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain: a journal of neurology. 2014.
15. Kristjansson A, Driver J. Priming in visual search: separating the effects of target repetition, distractor repetition and role-reversal. Vision Research. 2008; 48: 1217-32.
16. Jenkinson M, Beckmann CF, Behrens TE, et al. FSL. NeuroImage. 2012; 62: 782-90.
17. Donaghy C, Thurtell MJ, Pioro EP, et al. Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. Journal of Neurology, Neurosurgery, and Psychiatry. 2011; 82: 110-6.
18. Donaghy C, Pinnock R, Abrahams S, et al. Ocular fixation instabilities in motor neuron disease. A marker of frontal lobe dysfunction? Journal of Neurology. 2009; 256: 420-6.
19. Gizzi M, DiRocco A, Sivak M, et al. Ocular motor function in motor neuron disease. Neurology. 1992; 42: 1037-46.
20. Palmowski A, Jost WH, Prudlo J, et al. Eye movement in amyotrophic lateral sclerosis: a longitudinal study. Ger J Ophthalmol. 1995; 4: 355-62.
21. Moss HE, McCluskey L, Elman L, et al. Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. Journal of the Neurological Sciences. 2012; 314: 97-101.
22. Pringle CE, Hudson AJ, Munoz DG, et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain: a journal of neurology. 1992; 115: 495-520.
23. Evdokimidis I, Constantinidis TS, Gourtzelidis P, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. J Neurol Sci. 2002; 195: 25-33.
24. Donaghy C, Pinnock R, Abrahams S, et al. Slow saccades in bulbar-onset motor neuron disease. Journal of Neurology. 2010.
25. Burrell JR, Carpenter RH, Hodges JR, et al. Early saccades in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 294-301.
26. Lawyer T Jr, Netsky MG. Amyotrophic lateral sclerosis: a clinico-Anatomic study of 53 cases. ArchNeurol. 1953; 69: 171-92.
27. Harvey DG, Torack RM, Rosenbaum HE. Amyotrophic lateral sclerosis with ophthalmoplegia: a clinicopathologic study. Archives of Neurology. 1979; 36: 615-7.
28. Okamoto K, Hirai S, Amari M, et al. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathologica. 1993; 85: 458-62.
29. Mizuno Y, Fujita Y, Takatama M, et al. Comparison of phosphorylated TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS and ALS disorders. Journal of the Neurological Sciences. 2012; 315: 20-5.
30. Mizutani T, Aki M, Shiozawa R, et al. Development of ophthalmoplegia in amyotrophic lateral sclerosis during long-Term use of respirators. Journal of the Neurological Sciences. 1990; 99: 311-9.
31. Liu JX, Brannstrom T, Andersen PM, et al. Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors. PloS One. 2013; 8: e57473.
32. Mosier DR, Siklos L, Appel SH. Resistance of extraocular motor neuron terminals to effects of amyotrophic lateral sclerosis sera. Neurology. 2000; 54: 252-5.
33. Kaplan A, Spiller KJ, Towne C, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014; 81: 333-48.
34. Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurology. 2013; 12: 368-80.
35. Lakerveld J, Kotchoubey B, Kubler A. Cognitive function in patients with late stage amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 2008; 79: 25-9.
36. Robinson KM, Lacey SC, Grugan P, et al. Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six-month longitudinal study. Journal of Neurology, Neurosurgery, and Psychiatry. 2006; 77: 668-70.
37. Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population based longitudinal study. Neurology. 2013; 80: 1590-7.
38. Meier SL, Charleston AJ, Tippett LJ. Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis. Brain: a journal of neurology. 2010; 133: 3444-57.
39. Abrahams S, Goldstein LH, Al Chalabi A, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1997; 62: 464-72.
40. Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, et al. Cognitive function in bulbar-And spinal-onset amyotrophic lateral sclerosis A longitudinal study in 52 patients. Journal of Neurology. 2005.
41. Zalonis I, Christidi F, Paraskevas G, et al. Can executive cognitive measures differentiate between patients with spinal-And bulbar-onset amyotrophic lateral sclerosis? Archives of clinical neuropsychology: the official journal of the National Academy of Neuropsychologists. 2012; 27: 348-54.
42. Caselli RJ, Smith BE, Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurology. 1995; 45: 2005-9.
43. Piquard A, Le Forestier N, Baudoin-Madec V, et al. Neuropsychological changes in patients with primary lateral sclerosis. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2006; 7: 150-60.
44. Grace GM, Orange JB, Rowe A, et al. Neuropsychological functioning in PLS: a comparison with ALS. Can J Neurol Sci. 2011; 38: 88-97.
45. Tan CF, Kakita A, Piao YS, et al. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathologica. 2003; 105: 615-20.
46. Kiernan JA, Hudson AJ. Frontal lobe atrophy in motor neuron diseases. Brain: a journal of neurology. 1994; 117: 747-57.
47. Kuipers-Upmeijer J, de Jager AE, Hew JM, et al. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry. 2001; 71: 615-20.
48. Canu E, Agosta F, Galantucci S, et al. Extramotor damage is associated with cognition in primary lateral sclerosis patients. PloS One. 2013; 8: e82017.
49. Meoded A, Kwan JY, Peters TL, et al. Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis. Dementia and Geriatric Cognitive Disorders extra. 2013; 3: 233-50.
50. Anderson EJ, Jones DK, OGorman RL, et al. Cortical network for gaze control in humans revealed using multimodal MRI. Cerebral cortex (New York, NY: 1991). 2012; 22: 765-75.
51. Kennard C, Mannan SK, Nachev P, et al. Cognitive processes in saccade generation. Annals of the New York Academy of Sciences. 2005; 1039: 176-83.
52. Turner MR, Agosta F, Bede P, et al. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012; 6: 319-37.
53. Boxer AL, Garbutt S, Seeley WW, et al. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimers disease. Archives of Neurology. 2012; 69: 509-17.
54. Burrell JR, Hornberger M, Carpenter RH, et al. Saccadic abnormalities in frontotemporal dementia. Neurology. 2012; 78: 1816-23.
55. Jamadar SD, Fielding J, Egan GF. Quantitative meta-Analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Frontiers in Psychology. 2013; 4: 749.
56. Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain: a journal of neurology. 1996; 119: 2105-20.
57. Witiuk K, Fernandez-Ruiz J, McKee R, et al. Cognitive Deterioration and Functional Compensation in ALS Measured with fMRI Using an Inhibitory Task. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2014; 34: 14260-71.
58. Wessel JR, Reynoso HS, Aron AR. Saccade suppression exerts global effects on the motor system. Journal of Neurophysiology. 2013; 110: 883-90.
59. Curtis CE, Connolly JD. Saccade preparation signals in the human frontal and parietal cortices. Journal of Neurophysiology. 2008; 99: 133-45.
60. Pa J, Dutt S, Mirsky JB, et al. The functional oculomotor network and saccadic cognitive control in healthy elders. NeuroImage. 2014; 95: 61-8.
61. Pierrot-Deseilligny C, Muri RM, Ploner CJ, et al. Decisional role of the dorsolateral prefrontal cortex in ocular motor behaviour. Brain: a journal of neurology. 2003; 126: 1460-73.
62. Stuphorn V, Schall JD. Executive control of countermanding saccades by the supplementary eye field. Nature neuroscience. 2006; 9: 925-31.
63. Ziemann U, Winter M, Reimers CD, et al. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis: evidence from paired transcranial magnetic stimulation. Neurology. 1997; 49: 1292-8.
64. Vucic S, Cheah BC, Yiannikas C, et al. Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol. 2011; 122: 1860-6.
65. Turner MR, Kiernan MC. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2012; 13: 245-50.
66. Arbuthnott K, Frank J. Trail Making Test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000; 22: 518-28.
67. Gaudino EA, Geisler MW, Squires NK. Construct validity in the Trail Making Test: what makes part B harder? J Clin Exp Neuropsychol. 1995; 17: 529-35.
68. Stuss DT, Bisschop SM, Alexander MP, et al. The Trail Making Test: a study in focal lesion patients. Psychological Assessment. 2001; 13: 230-9.
69. Zakzanis KK, Mraz R, Graham SJ. An fMRI study of the Trail Making Test. Neuropsychologia. 2005; 43: 1878-86.
70. Hagen K, Ehlis AC, Haeussinger FB, et al. Activation during the Trail Making Test measured with functional near-infrared spectroscopy in healthy elderly subjects. NeuroImage. 2014; 85: 583-91.
71. Wolfe JM, Horowitz TS, Kenner N, et al. How fast can you change your mind? The speed of top-down guidance in visual search. Vision Research. 2004; 44: 1411-26.
72. Rippon GA, Scarmeas N, Gordon PH, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Archives of Neurology. 2006; 63: 345-52.
73. Anderson EJ, Mannan SK, Husain M, et al. Involvement of prefrontal cortex in visual search. Experimental Brain Research. 2007; 180: 289-302.
74. Volpato C, Piccione F, Silvoni S, et al. Working memory in amyotrophic lateral sclerosis: auditory event-related potentials and neuropsychological evidence. Journal of clinical neurophysiology: official publication of the American Electroencephalographic Society. 2010; 27: 198-206.
75. Hammer A, Vielhaber S, Rodriguez-Fornells A, et al. A neurophysiological analysis of working memory in amyotrophic lateral sclerosis. Brain Research. 2011; 1421: 90-9.
76. Abrahams S, Newton J, Niven E, et al. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013.
77. Munte TF, Troger MC, Nusser I, et al. Abnormalities of visual search behaviour in ALS patients detected with event-related brain potentials. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999; 1: 21-7.
78. Nobre AC, Coull JT, Walsh V, et al. Brain activations during visual search: contributions of search efficiency versus feature binding. NeuroImage. 2003; 18: 91-103.
79. Shulman GL, McAvoy MP, Cowan MC, et al. Quantitative analysis of attention and detection signals during visual search. Journal of Neurophysiology. 2003; 90: 3384-97.
80. Monosov IE, Thompson KG. Frontal eye field activity enhances object identification during covert visual search. Journal of Neurophysiology. 2009; 102: 3656-72.
81. Abrahams S, Newton J, Niven E, et al. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 9-14.
82. Turner MR, Benatar M. Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle and Nerve. 2014.
83. Douaud G, Filippini N, Knight S, et al. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain: a journal of neurology. 2011; 134: 3470-9.
84. Agosta F, Canu E, Valsasina P, et al. Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiology of Aging. 2013; 34: 419-27.
85. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population based cohort study. Lancet Neurology. 2012.
86. Irwin DJ, McMillan CT, Brettschneider J, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 2013; 84: 163-9.
87. Thurtell MJ, Pioro EP, Leigh RJ. Abnormal eye movements in Kennedy disease. Neurology. 2009; 72: 1528-30.